Searchable abstracts of presentations at key conferences in endocrinology

ea0015p78 | Clinical practice/governance and case reports | SFEBES2008

Zoledronate associated severe hypocalcaemia causing bradyarrhythmia that required urgent cardiac pacing

Bdiri Ashref , Lawrence James , Jones A , Smith Martin

A 71-year-old man with carcinoma of prostate and bony metastasis, presented with acute bradyarrhythmia, severe hypocalcaemia and acute renal failure 72 h after intravenous infusion of zoledronate. Before therapy, serum calcium was 2.14 mmol/l (normal, 2.10–2.55 mmol/l), serum phosphate 1.4 mmol/l (normal, 0.8–1.5 mmol/l), serum creatinine 95 umol/l and eGFR 74 ml/min. 25OH vitamin D was not measured. Three days later he presented with a syncopal episode. Initial bloo...

ea0015p87 | Clinical practice/governance and case reports | SFEBES2008

Sarcoidosis associated hypercalcaemia and renal failure mimicking lymphoma

Bdiri Ashref , Smith Martin , Lawrence James

We describe two cases of sarcoidosis associated hypercalcaemia, renal failure and anaemia mimicking lymphoma. The diagnosis was made by lymph node biopsy. Within weeks of starting oral steroids, symptoms resolved and biochemical abnormalities almost normalized.Case 1: A 66-year-old lady, presented with generalized weakness, lymphadenopathy and splenomegaly. Hb 96 g/l, MCV 91, urea 16.6 mmol/l, creatinine 227 umol/l, eGFR 15 ml/min, serum calcium 3.4 mmol...

ea0081ep123 | Adrenal and Cardiovascular Endocrinology | ECE2022

The Adrenal that inCYSTS on causing pain

Horne Christopher , Tilley Charles , Smith Martin , Lockyer C Richard W

Adrenal lymphangiomatous cysts are rare, often found incidentally, but can also present in association with abdominal/loin pain or hypertension.1 They have occasionally been reported in association with hormone over secretion of either aldosterone, cortisol or catecholamines. We present a case of a 40-year-old serving soldier who was suddenly awoken with severe left sided abdominal and flank pain. Over the course of several months, he was forced to take time off wor...

ea0028p21 | Bone | SFEBES2012

An audit of vitamin D status among local multiple sclerosis patients

Lim Yuen Han , Pattman Stewart , Guadagno Joe , Duddy Martin , Smith Gillian , Wilkinson Carmel , Quinton Richard

Background: Multiple sclerosis (MS) is associated with low ambient ultraviolet B (UVB) light in childhood and in utero (relative risk of developing MS is 1.2 for those born in spring). Besides, the MS-linked HLA-DRB1 allele interacts strongly with vitamin D in vitro, and vitamin D levels are lower in MS patients. Fatigue and musculoskeletal aches/pains are prominent symptoms in both MS and vitamin D deficiency. Moreover, having any chronic disease may predispose to stay...

ea0077oc6.4 | Thyroid | SFEBES2021

AP-2 and Moesin Regulate the Internalisation of the Sodium-Iodide Symporter and Affect I125 Uptake in Thyroid Cancer Cells.

Thornton Caitlin , Brookes Kate , Alice Fletcher , Nieto Hannah , Zha Ling , Kocbiyik Merve , Read Martin , Smith Vicki , McCabe Chris

Dysregulation of sodium-iodide symporter (NIS) function is common in differentiated thyroid cancer, resulting in sub-optimal radioiodide therapy and poorer clinical outcome. Recent developments in identifying proteins that regulate the function of the sodium iodide symporter have highlighted two proteins involved in internalisation of NIS from the plasma membrane: AP-2 and moesin. Clathrin-mediated endocytosis (CME) of NIS is facilitated through the adaptor protein 2 (AP2) com...

ea0038oc5.1 | Thyroid and parathyroid | SFEBES2015

Functional consequences of germline mutations in a novel non-RET medullary thyroid cancer susceptibility gene

Read Martin , Smith Joel , Smith Vicki , Bosseboeuf Emy , Wake Naomi , Watkinson John , Wallis Yvonne , Maher Eamonn , McCabe Christopher , Woodward Emma

Whilst the majority of familial medullary thyroid cancer (MTC) is caused by germline mutations of the RET proto-oncogene, there are families and individuals with predisposition to MTC in whom no RET mutation has been identified (non-RET MTC). Recently, we identified novel mutations in a single gene termed MTC2 in non-RET MTC individuals by whole exome sequencing. The precise role of these MTC2 germline mutations in MTC tumorigenesis is however unclear. Here, we examined the fu...

ea0034p173 | Neoplasia, cancer and late effects | SFEBES2014

The first reported mutations in the pituitary tumor-transforming gene binding factor

Imruetaicharoenchoke Waraporn , Read Martin , Smith Joel , Smith Vicki , Modasia Bhavika , Poole Vikki , Watkins Rachel , Jayne Franklyn , Boelaert Kristien , McCabe Christopher

PBF is a ubiquitous glycoprotein which is over-expressed particularly in endocrine and endocrine-related cancers. Previously classified as a proto-oncogene, 11 substitution-missense mutations of PBF have now been reported in tumours from patients with ovarian, prostate and colorectal cancers via the COSMIC database, suggesting PBF may in fact be an oncogene. We have therefore examined the biological implications of all 11 mutations. Substitution mutations, which occurred acros...

ea0034p361 | Steroids | SFEBES2014

Endogenous androgen-mediated modulation of neointima formation is independent of vascular androgen receptor

Wu Junxi , Hadoke Patrick , Mair Iris , Lim Win Gel , Millar Eileen , Milne Laura , Denvir Martin , Smith Lee

Aims: Low circulating testosterone levels are associated with increased cardiovascular risk and there is evidence that androgens inhibit arterial lesion formation. This investigation addressed the hypothesis that androgens directly inhibit neointimal lesion formation by stimulation of vascular androgen receptor.Methods and results: Mice were generated with selective deletion of androgen receptor from vascular (endothelial or smooth muscle) cells. Castrat...

ea0028p141 | Neoplasia, cancer and late effects | SFEBES2012

Oncogenic levels of PBF aberrantly affect p53 function leading to increased genetic instability in thyroid cancer

Seed Robert , Ryan Gavin , Read Martin , Smith Vicki , Lewy Greg , Sharma Neil , Kwan Perkin , Boelaert Kristien , Franklyn Jayne , McCabe Christopher

p53 is rarely mutated in thyroid papillary carcinomas, despite the thyroid being highly sensitive to ionising radiation. The pituitary tumor transforming gene binding factor (PBF) is a proto-oncogene overexpressed in thyroid cancer. Oncogenic levels of PBF result in cell transformation in vitro and tumourigenesis in vivo. By serendipity we have found that PBF interacts directly with the tumour suppressor protein p53. In light of these data we have investigated th...

ea0038oc5.4 | Thyroid and parathyroid | SFEBES2015

A novel modulator of cellular invasion and metastasis in endocrine cancer

Watkins Rachel , Imruetaicharoenchoke Waraporn , Sharma Neil , Gentillin Erica , Bosseboeuf Emy , Kwan Perkin , Fletcher Rachel , Mehanna Hisham , Boelaert Kristien , Read Martin , Smith Vicki , McCabe Christopher

Metastasis is a multistep process responsible for the majority of endocrine cancer deaths. Central to the ability of cells to move is the recruitment of actin fibres at the periphery of the cell by key proteins, especially the cortical actin binding protein cortactin. A full understanding of cortactin function is required in order to address metastatic cell activity within endocrine cancer. We used IP-MS to discover protein binding partners, and now identify the proto-oncogene...